The Hindu·3 min read·medium
Generics maker Laurus Lab’s net profit more than doubles in Q1 on strong CDMO business growth
T
The Hindu Bureau
✦AI Summary
Laurus Labs reported a significant increase in net profit for the June quarter, with revenue more than doubling year-on-year. The growth was primarily driven by a 67% surge in the company's CDMO business and strong performance in its generics division.
Generic drugmaker Laurus Labs’ consolidated net profit more than doubled year-on-year (YoY) to ₹361.99 crore for the June quarter, driven by a 29% jump in revenue.
businesshealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in